DENTAL FILLERS, METHODS, COMPOSITIONS INCLUDING A CASEINATE - The present application provides dental fillers, and methods of making and using dental fillers that include a treated surface that includes a caseinate. Dental compositions including such dental fillers can be useful for delivering ions to the oral environment. Dental compositions, and methods of using dental compositions that include a caseinate and a hardenable resin or a water-dispersible, polymeric film former are also provided.

12-10-2009

20130302437

COMPOSITION COMPRISING AN ELICITOR OF THE PLANT IMMUNE SYSTEM - The present invention generally relates to new plant elicitor compositions, and the use of these compositions in agricultural applications, more particularly to protect plants against (infection by) plant pathogens and the corresponding methods of, and uses in, the protection of plants and crops by application of these compositions.

11-14-2013

20110033557

PHARMACEUTICAL COMPOSITION AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF - A pharmaceutical composition comprises a diluted water solution containing hydrogen peroxide between about 1% and about 40%, at least a stabilizing compound comprised between about 0% and about 0.2% and at least synergizing compound comprised between about 0% and about 1.5% in weight.

OPHTHALMIC FORMULATIONS AND USES THEREOF - Provided by the present invention are compositions or formulations suitable for application to a patient's eyes which utilizes a topical ophthalmically-acceptable formulation comprising a therapeutically-effective amount of an ophthalmically-active antimicrobial agent, and an ophthalmically-active anti-inflammatory or steroidal agent in combination with physiologic levels of serum electrolytes in an ophthalmic formulation for the treatment of changes in the normal eye condition. The invention also includes methods of treating patient's having an ophthalmic disease, injury or disorder, utilizing the compositions or formulations. Also provided are kits comprising the compositions or formulations and a means of applying the compositions or formulation to the patient's eyes.

FUNGICIDAL COMPOSITIONS AND METHODS OF ENHANCING PLANTS SUCH AS TURFGRASS - The present disclosure provides fungicidal compositions and methods of enhancing vegetation, e.g. turfgrass. The composition may be a combination of chlorothalonil, a phosphonate and a phythalocyanine dye. Phthalocyanine green dye is preferred. This composition is mixed with water and inert ingredients such as surfactants and other inert ingredients. A phosphonate is preferably a phosphite, such as a potassium or urea phosphite. The composition is mixed in water with inert ingredients such as surfactants and other inert ingredients for application to plants, such as turf grass and ornamental plants.

11-18-2010

20110135749

LOW SHRINKAGE MULTIFUNCTIONAL SSQ RESINS - The present invention relates to low shrinkage multi functionalized silsesquioxane (SSQ) derivatives, to nanocomposite materials comprising these SSQ's and to the use of the nanocomposite material as a polymerizable resin in biologically compatible materials.

LITHIUM AND A BETA-SECRETASE INHIBITOR FOR THE TREATMENT OF ALZHEIMER'S DISEASE - This invention is a pharmaceutical composition comprising of lithium as an active ingredient, to decrease intracellular calcium ion concentrations, and a beta-secretase inhibitor as an active ingredient, to reduce beta-secretase activity; for the treatment and prevention of disease, including disease characterized by the abnormal cleavage of amyloid precursor protein.

09-18-2014

20100255116

FUNGICIDAL COMPOSITION AND METHOD FOR CONTROLLING NOXIOUS FUNGI - A fungicidal composition is provided. A fungicidal composition comprising synergistically effective amounts of (a) a carboxylic acid amide derivative of the formula (I) or its salt: wherein B is a heterocyclic group which may be substituted; each of R

10-07-2010

20130052274

NUTRITIONAL COMPOSITIONS INCLUDING EXOGENOUS VITAMIN K2 - Nutritional compositions and methods of making and using the nutritional compositions are provided. In a general embodiment, the present disclosure provides a nutritional composition including exogenous vitamin K2. The nutritional compositions may further include an additional component selected from the group consisting of phosphorus, magnesium, zinc, iron, copper, manganese, calcium, vitamin D, osteopontin and combinations thereof.

02-28-2013

20100330194

Silicon Substituted Phosphates - The invention is various applications of silicon substituted phosphates of various chemical composition and granular sizes in direct application or in combination with other materials, not previously claimed in prior art used to treat the various medical conditions described.

12-30-2010

20100034898

CARTILAGE SIMULATING BIO-MATERIAL COMPOSITION AND METHOD - The present invention relates to a method for providing cartilage proliferation generally comprising: supplying a dry potassium phosphate based mixture comprising: monobasic potassium phosphate, a metal oxide, and a tertiary calcium phosphate, wherein the weight percent ratio of monobasic potassium phosphate to metal oxide is between about 3:1 and 1:1; mixing the dry potassium phosphate based mixture with an aqueous solution forming an activated cartilage proliferating slurry (ACPS); applying an amount of the activated potassium phosphate based ACPS to a site of desired cartilage proliferation. In one or more preferred embodiments the dry mixture further comprises: a sugar (or sugar derivate/replacement) and/or mono-sodium phosphate.

METHOD FOR THE EFFICIENT AND CONTINUOUS GROWTH AND HARVESTING OF NUTRIENT-RICH PHYTOPLANKTON AND METHODS OF USING THE SAME - Methods of growing and harvesting multiple species of phytoplankton are disclosed herein. The method generally includes four steps, namely: (1) collecting phytoplankton seawater containing multiple species of naturally-occurring phytoplankton directly from a source of seawater; (2) adding nutrients to the phytoplankton seawater to proliferate the multiple species of naturally-occurring phytoplankton to a predetermined density; (3) separating the multiple species of naturally-occurring phytoplankton from the phytoplankton seawater to form a phytoplankton concentrate; and (4) collecting the phytoplankton concentrate such that the collected phytoplankton of the phytoplankton concentrate remain in a substantially intact cellular state.

07-29-2010

20140199410

EDIBLE BROWN ALGAE EXTRACT WITH A LOW IODINE CONTENT - The invention relates to a brown algae extract containing less than 50 ppm of iodine and between 5 and 15%, and preferably between 8 and 10%, of polyphenols, said percentage of polyphenols being expressed as a chlorogenic acid equivalent in relation to the dry weight of the extract, the invention also relating to an oral absorption composition comprising such an extract, and to a method for preparing the extract according to the invention.

07-17-2014

20130177655

PREVENTING OR TREATING AGENT FOR GLAUCOMA - A preventing or treating agent for glaucoma is provided. This drug has a strong action of reducing intraocular pressure such that the intraocular pressure can be reduced even from the normal intraocular pressure. More specifically, a prophylactic or therapeutic agent for glaucoma, a preventing or treating agent for ocular hypertension, and eye drops containing (S)-(−)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl homopiperazine or its salt and phosphoric acid or its salt are provided.

07-11-2013

20140255509

COMPOSITION - Compositions and formulations comprising a non-neutralised tocol phosphate and a vitamin A compound, which are suitable for the treatment of inflammation and/or infection in breast or udder tissue, more particularly in a mammary gland, reducing the somatic cell count in a lactating subject and supplementing vitamin E levels in a subject.

09-11-2014

20150093449

Method of Using Silicon Substituted Phosphates to Improve Healing of Bone and Soft Tissue - A method of use of silicon substituted phosphates that improves bone and soft tissue growth resulting in better adhesion and fixation of implanted prosthetics, which may be used as part of a tissue engineering scaffold for ligament replacement and results in improved healing of healing of damaged bone and soft tissue ulcers. The silicon substituted phosphates of various chemical composition and granular sizes may be used in direct application or in combination with other materials, not previously claimed in prior art used to treat the various medical conditions described.

Compositions and Methods For Preventing or Treating Chronic Renal Failure in Felines With Hyperthyroidism - The invention relates to compositions for preventing chronic renal failure (CRF) in felines with hyperthyroidism wherein the compositions comprise (1) from about 28 to about 35% protein, the protein comprising at least about 75% vegetable protein, and (2) from about 0.1 to less than about 1 mg/kg iodine and/or from about 0.1 to about 1 mg/kg selenium. The invention also relates to compositions for treating CRF in hyperthyroid felines wherein the compositions comprise (1) from about 28 to about 35% protein, the protein comprising at least about 75% vegetable protein, and (2) from about 0.1 to less than about 0.3 mg/kg iodine and/or from about 0.1 to about 1 mg/kg selenium. The invention further relates to methods for preparing and using such compositions, articles of manufacture comprising such compositions, and means for communicating information about such compositions, methods, and articles of manufacture.

10-29-2009

20100086618

Methods and Systems for Mineralization of Demineralized Tissue - Disclosed are systems, methods, compositions and kits for mineralizing tissue, particularly dental tissue. The methods, compositions and kits may be used to strengthen and prevent weakening of the tissue. For example, the methods, compositions and kits may be used for treating and filling cavities in teeth caused by tooth decay.

FORMULATIONS OF PHOSPHITES - The invention relates to a composition comprising a phosphite compound, a lignin compound and a pesticide adjuvant. The invention further relates to the use of the composition of the invention, and to methods of reducing the phytotoxicity of a composition comprising a phosphite compound and an adjuvant. The invention also relates to a method for protecting an agricultural plant from a plant disease comprising applying to said agricultural plant a composition according to the invention.

02-07-2013

20110142957

METHOD OF TREATING PARTURIENT PLACENTAL MAMMALS IN ORDER TO REDUCE MATERNAL AND/OR UTERINE EXHAUSTION - The present invention relates to a method of facilitating the birth process of placental mammals, especially to a method of reducing delays in the birth process and, thereby, complications resulting there from that may negatively affect the health and wellbeing of the mother and increase the incidence of stillbirths and/or neonatal mortality. According to the present invention delays in parturition that result from maternal and/or uterine exhaustion may be prevented or reduced by the administration of an effective amount of one or more psychomotor stimulants to the parturient mammal prior to and/or during parturition. Said psychomotor stimulant is selected from the group comprising xanthines and amphetamines.

Homeopathic Remedies and Methods for Enhancing Weight Loss - Homeopathic compositions and formulations are disclosed. In one embodiment, compositions and formulations are disclosed that aid in weight loss and maintenance of a healthy weight. In another embodiment, methods are disclosed for producing homeopathic compositions and formulations. In still another embodiment, methods are disclosed for helping an individual lose weight.

NUTRITIONAL COMPOSITIONS AND METHODS FOR OPTIMIZING DIETARY ACID-BASE POTENTIAL - Nutritional compositions having the potential to reduce metabolic acid load and methods of making and using the nutritional compositions are provided. In an embodiment, the present disclosure provides methods of selecting and administering nutritional compositions to patients. The methods may include modifications to calculating a metabolic acid potential of a nutritional composition, calculating a base content of a nutritional composition and subtracting the base content from the acid content to determine a potential renal acid load (“PRAL”) value. The present disclosure also provides computer implemented processes for predicting PRAL values.

05-23-2013

20120219635

Devices and Methods for Tissue Engineering - A bioactive tissue scaffold is fabricated from glass fiber that forms a rigid three-dimensional porous matrix having a bioactive composition. Porosity in the form of interconnected pore space is provided by the pore space between the glass fiber in the porous matrix. Mechanical properties such as strength, elastic modulus, and pore size distribution is provided by the three-dimensional matrix that is formed by bonded overlapping and intertangled fibers. The bioactive tissue scaffold can be formed from raw materials that are not bioactive, but rather precursors to bioactive materials. The bioactive tissue scaffold supports tissue in-growth to provide osteoconductivity as a resorbable tissue scaffold, used for the repair of damaged and/or diseased bone tissue.

08-30-2012

20150366906

ALKALINE DRINK - Alkaline drink compositions buffered to have a neutral to alkaline pH and methods of treatment using the same.

Physico-Chemical-Managed Killing of Penicillin-Resistant Static and Growing Gram-Positive and Gram-Negative Vegetative Bacteria - Systems and methods for the use of compounds from the Hofmeister series coupled with specific pH and temperature to provide rapid physico-chemical-managed killing of penicillin-resistant static and growing Gram-positive and Gram-negative vegetative bacteria. The systems and methods represent the more general physico-chemical enhancement of susceptibility for a wide range of pathological macromolecular targets to clinical management by establishing the reactivity of those targets to topically applied drugs or anti-toxins.

05-10-2012

20140234436

SYSTEMS AND METHODS FOR CAPTURE, STORAGE, AND SUPPLYING PHOSPHINE GAS - A system and process for generating and packaging phosphine gas, in which the process includes: reacting water and aluminum phosphide to generate phosphine, and providing the phosphine in a gas mixture at a phosphine concentration below a lower explosive limit; adsorptively removing phosphine from the gas mixture; and packaging the removed phosphine in a fluid storage and dispensing vessel.

08-21-2014

20140234435

SETTING OF HARDENABLE BONE SUBSTITUTE - The invention relates to hardenabie ceramic bone substitute compositions having improved setting, powders for such compositions and methods for their manufacture and use in medical treatment. More specifically the invention relates to hardenable bone substitute powder and hardenabie bone substitute paste with improved setting properties, comprising calcium sulfate and heat-treated hydroxyapatite (passivated HA), which bone substitute is suitable for treatment of disorders of supportive tissue such as bone loss, bone fracture, bone trauma and osteomyelitis.

AGENT FOR PREVENTION OR TREATMENT OF BLOOD GLUCOSE LEVEL ELEVATION - An object is to find a natural material having an activity of preventing the elevation of blood glucose level and to provide a means which is able to prevent or treat the diabetes and there is provided an agent for prevention or treatment of the elevated blood glucose level where a compound containing soluble silica and/or strontium is an active ingredient.

02-04-2010

20160015057

NUTRITIONAL SUPPLEMENT/FEED FORMULA AND METHODS OF USE THEREOF TO REDUCE DEVELOPMENT OF OSTEOCHONDROSIS DISSECANS (OCD) LESIONS - A novel dietary supplement and nutritional aid and methods for the manufacture and administration of the same are disclosed for the inhibition of OCD in afflicted animals, particularly horses. The present invention relates generally to a feed composition and methods of use thereof for reducing the development of Osteochondrosis Dissecans (OCD) lesions in predisposed young animals, particularly horses. More specifically the invention provides a nutritional formula that targets the metabolic deficiencies identified as being correlated with development of OCD.

01-21-2016

20120213861

2-CHLOROPENTAFLUOROPROPENE COMPOSITIONS AND METHOD OF USE FOR EXTERMINATION OF RODENTIA - Rodenticide compositions that include 2-chloropentafluoropropene, and methods of using such rodenticide compositions, are provided. The rodenticide compositions can be used as fumigants in space fumigation applications. In some examples, the rodenticide compositions can be used as drop-in replacements for methyl bromide in existing rodenticide compositions and methods of exterminating rodents using methyl bromide.

08-23-2012

20120301552

CaSR Antagonist - A compound represented by the following formula (1), a pharmaceutically acceptable salt thereof or an optically active form thereof:

11-29-2012

20110189303

METHODS FOR ENHANCING THE QUALITY OF LIFE OF A SENIOR ANIMAL - The present invention relates to methods for enhancing the quality of life of a senior or super senior animal by feeding the animal a composition comprising at least one omega-3 polyunsaturated fatty acid and various combinations of amino acids, minerals, and antioxidants in amounts effective to enhance alertness, improve vitality, protect cartilage, maintain muscle mass, enhance digestibility, and improve skin and pelage quality. Beneficial changes in expression of genes associated with several biological pathways may be induced in an animal by feeding it said composition and are consistent with an enhancement in the quality of life of said animal.

Vitamin Strip (V1) - The vitamin strip is made with gel, film, or dissolvable material safe for human consumption. It can encompass all the vitamins, minerals, medicines, or meal replacement elements safe for human intake. The vitamin strip (V1) can be made as a whole or as a strip of edible dissolvable material with any vitamin(s), mineral(s), medicine(s), or meal replacement element(s) safe for human consumption on the strip of edible dissolvable material.

09-29-2011

20110250288

FUNGICIDAL COMPOSITIONS AND METHODS OF ENHANCING TURFGRASS - The present disclosure provides fungicidal compositions and methods of enhancing vegetation, e.g. turfgrass. The composition may be a combination of chlorothalonil and malachite green dye. Malachite green oxalate is preferred. This composition is mixed with water and inert ingredients such as surfactants and other inert ingredients. A phonosphonate compound may be added, such as a phosphite. Potassium phosphite may be used. Urea phosphite is preferred. The composition is mixed in water with inert ingredients such as surfactants and other inert ingredients.

METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF KIDNEY DISEASE - Compositions for preventing or treating kidney disease comprising one or more food ingredients containing relatively low amounts of protein, sodium, and potassium, typically protein in amounts of from about 5% to about 40%, sodium in amounts of from about 0.01% to about 1%, and potassium in amounts of from about 0.01% to about 1%, and methods comprising administering such compositions to patients susceptible to or suffering from kidney disease for the purpose of preventing or treating kidney disease.

07-14-2011

20110195130

EDIBLE COMPOSITIONS - Disclosed are various embodiments of edible food compositions effective for neutralizing stomach acid. Further, the present invention is directed toward methods of preparing the edible composition and the methods for reducing stomach acidity by ingesting the edible composition. In one embodiment, the edible composition comprises sweetener, flour, fat, leavening agent, water, and an effective amount of acid neutralizing material. In one embodiment, the above ingredients are combined to form a heavy dough which is then rolled out, divided into sections, and baked, resulting in a cookie with effective antacid properties. Further disclosed are edible compositions for delivering calcium as a dietary supplement.

PREPARATION FOR TREATMENT OF MINERAL DEFICIENCY - The invention relates to a preparation having an improved taste, as well as to the use of said preparation for treatment of mineral deficiency. In accordance with the invention, it has been found possible to effectively mask the bad taste of even such notorious minerals as iron. As a result, patient compliance may be increased significantly by prescription of a preparation according to the invention, thereby increasing effective uptake of the deficient mineral.

METHOD OF TREATING PARTURIENT PLACENTAL MAMMALS IN ORDER TO REDUCE MATERNAL AND/OR UTERINE EXHAUSTION - The present invention relates to a method of facilitating the birth process of placental mammals, especially to a method of reducing delays in the birth process and, thereby, complications resulting there from that may negatively affect the health and wellbeing of the mother and increase the incidence of stillbirths and/or neonatal mortality. According to the present invention delays in parturition that result from maternal and/or uterine exhaustion may be prevented or reduced by the administration of an effective amount of one or more psychomotor stimulants to the parturient mammal prior to and/or during parturition. Said psychomotor stimulant is selected from the group comprising xanthines and amphetamines.

09-03-2009

20090117199

Method of treatment of cancer - A method for the treatment of cancer, particularly a metastatic melanoma or a neoplastic lesion, the method comprising intralesional administration of a hydrophilic vehicle comprising 4,5,6,7-Tetrachloro-2′,4′,5′,7′-tetraiodofluorescein, or a physiologically acceptable salt thereof, at a concentration of about 0.1 w/v % up to about 20 w/v % and an electrolyte comprising at least one cation selected from the group consisting of sodium, potassium, calcium and magnesium and at least one anion selected from the group consisting of chlorine, a phosphate and a nitrate, wherein the electrolyte is at a concentration of between about 0.1 w/v % and about 2 w/v % and the pH of the solution between about 4 to about 10.

05-07-2009

20080226744

DIETARY SUPPLEMENT AND RELATED METHOD - A composition including a unique combination of fruits, vegetables, herbs, and optionally vitamins, minerals and specialty ingredients. The composition can include a fruit ingredient, a vegetable ingredient and an herbal ingredient, wherein the fruit ingredient is at least one of pomegranate and citrus bioflavonoids, wherein the vegetable ingredient, is at least one of asparagus, lutein, lycopene and watercress, and wherein the herbal ingredient is at least one of basil, oregano and rosemary. The composition can be administered to subjects to correct a dietary deficiency of phytochemicals and other nutrients, improve plasma concentrations of antioxidant nutrients, and increase the activity of genetic mechanisms for DNA repair and stability.

09-18-2008

20080241270

FLUID COMPOSITION FOR INHIBITING SURGICAL ADHESION FORMATION AND RELATED METHOD OF PRODUCTION - A composition to inhibit the formation of adhesions that may arise at a surgical site. The composition includes an antioxidant in a carrier. The carrier is comprised of cocamide diethanolamine, diethanolamine and glycerin. The composition may include additional additives, such as euricamide and a compound including a polyethylene resin, calcium carbonate and a concentrated form of the carrier. The composition is produced by heating the carrier to a temperature, preferably about 375° F. and then adding the additives. The mixture is heated at temperature long enough to cause the antioxidant to leach into the liquid. The mixture is then cooled at room temperature and maintained in liquid form for ease of application to the surgical site where adhesion formation inhibition is desired. The composition is preferably degradable in vivo.

10-02-2008

Patent applications in class Phosphorus or phosphorus compound

Patent applications in all subclasses Phosphorus or phosphorus compound